Apellis Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$56.19 | $4.48 B | -14.98 | 69 |
ABOS
Acumen Pharmaceuticals, Inc. |
$1.12 | $69.36 M | -0.59 | 61 |
MDGL
Madrigal Pharmaceuticals, Inc. |
$300.75 | $6.18 B | -15.6 | 528 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $8.19 B | -16.47 | 355 |
MREO
Mereo BioPharma Group plc |
$2.66 | $441.22 M | -7.93 | 36 |
DAWN
Day One Biopharmaceuticals, Inc. |
$6.47 | $653.78 M | -9.92 | 181 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$6.33 | $566.05 M | -2.05 | 123 |
MRTX
Mirati Therapeutics, Inc. |
$0.00 | $4.12 B | -4.82 | 587 |
IMVT
Immunovant, Inc. |
$16.10 | $2.69 B | -5.76 | 362 |
BPMC
Blueprint Medicines Corporation |
$128.11 | $8.28 B | -51.24 | 682 |
INZY
Inozyme Pharma, Inc. |
$3.99 | $258.25 M | -2.38 | 67 |
XFOR
X4 Pharmaceuticals, Inc. |
$1.83 | $12.21 M | 1 | 143 |
TERN
Terns Pharmaceuticals, Inc. |
$3.83 | $355.03 M | -3.76 | 59 |
RXDX
Prometheus Biosciences, Inc. |
$0.00 | $9.56 B | -56.47 | 97 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
